Paech Christian, Wagner Franziska, Mensch Sebastian, Antonin Gebauer Roman
Department for Pediatric Cardiology, University of Leipzig-Heart Center, Leipzig, Germany.
Congenit Heart Dis. 2018 Nov;13(6):1064-1068. doi: 10.1111/chd.12682. Epub 2018 Oct 9.
Reflex vasovagal-or cardioinhibitory syncope is known to be a major cause of recurrent syncope in children. The mechanism of vasovagal syncope (VVS) is an interaction between a vagally mediated bradycardia or asystole and a more or less manifest vasodilatory component. Although pacing is not advisable as a standard approach in patients with VVS, it remains a treatment option of last resort in exceptionally severe cases, or patients with contraindication or refractoriness to drug therapy and life style changes. To effectively avoid VVS in these patients, the pacemaker has to both prevent bradycardia and to compensate for the vasodilatory component. Therefore, this study aimed to evaluate a simple pacemaker setting (VVI pacing with hysteresis) with the potential to prevent VVS in affected children.
Clinical data of patients, who were presented to the Department for Pediatric Cardiology, Heart Center Leipzig, in the period of 2001-2017 for cardiac pacemaker implantation for cardioinhibitory syncope or pallid breath-holding spells, were collected retrospectively.
Eleven pediatric patients, median age 2.7 (0.8-17) years, were included. Pacemaker settings are depicted. In 10 out of 11 patients, an entire abolishment of syncope could be achieved (P = .002).
The presented VVI pacing with hysteresis seems to be a promising pacemaker setting in pediatric patients with cardioinhibitory syncope who need a pacemaker. Unnecessary ventricular stimulation is effectively avoided, while cardiac output is preserved during cardioinhibition, by providing a sufficient paced heart rate, compensating for the often present vasodilatory component.
反射性血管迷走神经性或心脏抑制性晕厥是儿童反复晕厥的主要原因。血管迷走性晕厥(VVS)的机制是迷走神经介导的心动过缓或心搏停止与或多或少明显的血管舒张成分之间的相互作用。虽然起搏不作为VVS患者的标准治疗方法,但在极少数严重病例、或对药物治疗和生活方式改变有禁忌或难治的患者中,它仍然是最后的治疗选择。为了有效避免这些患者发生VVS,起搏器必须既能预防心动过缓,又能补偿血管舒张成分。因此,本研究旨在评估一种简单的起搏器设置(带滞后的VVI起搏)预防受影响儿童VVS的潜力。
回顾性收集2001年至2017年期间因心脏抑制性晕厥或苍白性屏气发作而到莱比锡心脏中心儿科心脏病科接受心脏起搏器植入的患者的临床资料。
纳入11例儿科患者,中位年龄2.7(0.8 - 17)岁。描述了起搏器设置。11例患者中有10例完全消除了晕厥(P = 0.002)。
对于需要起搏器的心脏抑制性晕厥儿科患者,所提出的带滞后的VVI起搏似乎是一种有前景的起搏器设置。通过提供足够的起搏心率,补偿经常出现的血管舒张成分,有效避免了不必要的心室刺激,同时在心脏抑制期间保持心输出量。